Prevention of PTOA via regulation of the cytomechanics of chondrocytes

Information

  • Research Project
  • 10250312
  • ApplicationId
    10250312
  • Core Project Number
    R01AR074472
  • Full Project Number
    5R01AR074472-02
  • Serial Number
    074472
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/1/2020 - 3 years ago
  • Project End Date
    7/31/2024 - a month from now
  • Program Officer Name
    KIRILUSHA, ANTHONY G
  • Budget Start Date
    8/1/2021 - 2 years ago
  • Budget End Date
    7/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/17/2021 - 2 years ago
Organizations

Prevention of PTOA via regulation of the cytomechanics of chondrocytes

PROJECT SUMMARY Traumatic injuries in human joints can cause cartilage degeneration and lead to post-traumatic osteoarthritis. Few techniques are now available in practice to prevent the cartilage from degeneration after the joint injuries. Our research discovered that statins, a class of drugs used by 40 million US people to control the cholesterol levels, can effectively protect the cartilage from various OA-inducing factors. We found that statins can directly act on the cartilage cells and prevent them from degrading the cartilage matrix. In this project, we will determine the efficacy and mechanism of statins for the prevention of post-traumatic osteoarthritis. First, using a retrospective cohort study, we will determine the correlation between statin use and OA occurrence among the Delaware population. Second, using in vitro cell/tissue culture models, we will identify the cartilage- protective mechanisms of statin. Third, we will test the efficacy of statin for PTOA prevention using animal models. Outcome of this project can provide us justifications for the clinical trials of statin application on the patients with joint injuries. The long-term goal of this project is to pursuit an FDA approval for the repurpose of statins in joint treatment and PTOA prevention. If this project is successful, it will immediately increase the prescription adherence of 40 million current statin users, especially those at a high risk of osteoarthritis occurrence with a joint injury history.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R01
  • Administering IC
    AR
  • Application Type
    5
  • Direct Cost Amount
    213400
  • Indirect Cost Amount
    120406
  • Total Cost
    333806
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    846
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIAMS:23406\NIGMS:310400\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF DELAWARE
  • Organization Department
    ENGINEERING (ALL TYPES)
  • Organization DUNS
    059007500
  • Organization City
    NEWARK
  • Organization State
    DE
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    197160000
  • Organization District
    UNITED STATES